HOME | COUNTRIES | CITIES | COMPANIES | SPORTS | CARS
news videos images websites wiki
 


Genentech Company News

Tue, 07 May 2019 15:52:14 GMT
Playing Catch-up, Genentech's Oral Drug for SMA Shows Promise in Clinical Trials - BioSpace
Playing Catch-up, Genentech's Oral Drug for SMA Shows Promise in Clinical Trials BioSpace Genentech, a Roche company, presented data from its FIREFISH clinical trial of risdiplam in Type 1 spinal muscular atrophy (SMA) at the American Academy of ...
Mon, 15 Apr 2019 07:00:00 GMT
Black Genentech worker, accused of stealing half a sandwich, gets $233,126 in discrimination lawsuit - East Bay Times
Black Genentech worker, accused of stealing half a sandwich, gets $233,126 in discrimination lawsuit East Bay Times A black IT worker at Genentech was awarded nearly $250,000 last week after a jury agreed that his race-discrimination complaint was a factor in his firing.
Tue, 16 Apr 2019 07:00:00 GMT
Black Genentech worker in Vacaville, accused of stealing half a sandwich, gets $233,126 in discrimination lawsuit - Daily Democrat
Black Genentech worker in Vacaville, accused of stealing half a sandwich, gets $233,126 in discrimination lawsuit Daily Democrat A black IT worker at Genentech was awarded nearly $250,000 last week after a jury agreed that his race-discrimination complaint was a factor in his firing.
Thu, 09 May 2019 15:58:00 GMT
Roche's Ocrevus continues winning streak as NICE flip-flops on initial rejection - FiercePharma
Roche's Ocrevus continues winning streak as NICE flip-flops on initial rejection FiercePharma Roche's MS superstar Ocrevus has run into few obstacles on its path to nearly $1 billion in global sales this year. Now, one major hurdle on the drug's ...
Mon, 29 Apr 2019 07:00:00 GMT
New Genentech Data at the 2019 AAN Annual Meeting Showcase Breadth and Promise of Neuroscience Portfolio - BioSpace
New Genentech Data at the 2019 AAN Annual Meeting Showcase Breadth and Promise of Neuroscience Portfolio BioSpace Risdiplam data from Part 1 of pivotal FIREFISH study show infants with Type 1 spinal muscular atrophy achieve key motor milestones and improved survival after ...
Fri, 26 Apr 2019 07:00:00 GMT
BRIEF-Forty Seven Inc Expands Collaboration With Genentech To Include Third Clinical Trial In Non-Hodgkin’S Lymphoma - Reuters
BRIEF-Forty Seven Inc Expands Collaboration With Genentech To Include Third Clinical Trial In Non-Hodgkin’S Lymphoma Reuters April 26 (Reuters) - Forty Seven Inc: * FORTY SEVEN INC. EXPANDS COLLABORATION WITH GENENTECH TO INCLUDE THIRD CLINICAL TRIAL IN ...
Wed, 01 May 2019 17:14:36 GMT
Immuno-Oncology Firm to Collaborate on Third Clinical Trial with Genentech - Streetwise Reports
Immuno-Oncology Firm to Collaborate on Third Clinical Trial with Genentech Streetwise Reports Descriptions of the new study and upcoming data readouts for this California-based firm were provided in an H.C. Wainwright & Co. report.
Thu, 09 May 2019 21:25:00 GMT
Promising Huntington's Disease Drug Enters Large Study : Shots - Health News - NPR
Promising Huntington's Disease Drug Enters Large Study : Shots - Health News NPR More than 600 people will take part in study to test a promising treatment for Huntington's disease, a fatal inherited condition. The experimental drug interferes ...
Thu, 25 Apr 2019 07:00:00 GMT
EuroBiotech Report—Genentech backs U.K. accelerator, GSK punts heart drug, Boehringer and more - FierceBiotech
EuroBiotech Report—Genentech backs U.K. accelerator, GSK punts heart drug, Boehringer and more FierceBiotech Welcome to the latest edition of our weekly EuroBiotech Report. We start this week in Cambridge, U.K., where life science accelerator Start Codon revealed it ...
Thu, 09 May 2019 05:12:59 GMT
Global Human Growth Hormone Drugs Market 2019 – Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech, Inc. (US) - Daily Post Times
Global Human Growth Hormone Drugs Market 2019 – Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech, Inc. (US) Daily Post Times Global Human Growth Hormone Drugs Market Research Report helps market readers to take significant steps towards gaining details of the competitive ...